Given the association of RA with DLBCL and the increased risk of both secondary skin cancer and Richter's transformation in CLL/SLL, caution is warranted when considering TNF-alpha inhibitors in these patients. This evidence concerns the gene TNF and B-cell chronic lymphocytic leukemia.